agilon health, inc. (NYSE:AGL - Get Free Report)'s stock price gapped up prior to trading on Wednesday after the company announced better than expected quarterly earnings. The stock had previously closed at $4.46, but opened at $4.71. agilon health shares last traded at $3.58, with a volume of 1,451,565 shares trading hands.
The company reported $0.03 EPS for the quarter, topping analysts' consensus estimates of ($0.01) by $0.04. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. The business had revenue of $1.53 billion for the quarter, compared to the consensus estimate of $1.50 billion. During the same period in the prior year, the firm earned ($0.02) EPS. The company's revenue for the quarter was down 4.5% compared to the same quarter last year.
Wall Street Analyst Weigh In
A number of equities research analysts have recently issued reports on the stock. Barclays boosted their price target on shares of agilon health from $2.00 to $3.00 and gave the company an "underweight" rating in a research note on Thursday. JMP Securities restated a "market perform" rating on shares of agilon health in a report on Monday, April 28th. TD Cowen upped their price target on shares of agilon health from $3.50 to $6.00 and gave the company a "hold" rating in a research report on Tuesday, April 15th. Needham & Company LLC reiterated a "hold" rating on shares of agilon health in a report on Friday, March 21st. Finally, Cowen reissued a "hold" rating on shares of agilon health in a research note on Tuesday, April 15th. Two analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and four have issued a buy rating to the stock. According to MarketBeat.com, agilon health has an average rating of "Hold" and an average price target of $4.89.
Get Our Latest Analysis on agilon health
Institutional Investors Weigh In On agilon health
A number of institutional investors and hedge funds have recently modified their holdings of the business. Vanguard Group Inc. boosted its holdings in shares of agilon health by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company's stock valued at $59,114,000 after buying an additional 272,787 shares during the period. Capital International Investors increased its stake in shares of agilon health by 72.0% during the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company's stock worth $42,431,000 after purchasing an additional 9,346,295 shares during the period. Millennium Management LLC raised its stake in agilon health by 187.8% during the fourth quarter. Millennium Management LLC now owns 7,212,525 shares of the company's stock worth $13,704,000 after acquiring an additional 4,706,357 shares in the last quarter. Geode Capital Management LLC increased its position in agilon health by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company's stock valued at $13,168,000 after acquiring an additional 35,207 shares during the period. Finally, Charles Schwab Investment Management Inc. increased its position in shares of agilon health by 8.8% during the first quarter. Charles Schwab Investment Management Inc. now owns 4,939,576 shares of the company's stock worth $21,388,000 after buying an additional 398,027 shares during the period.
agilon health Stock Performance
The company has a market capitalization of $1.23 billion, a price-to-earnings ratio of -3.15 and a beta of 0.38. The company's 50-day moving average price is $4.27 and its two-hundred day moving average price is $3.19. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29.
About agilon health
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Stories
Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
